F. Sherif et L. Oreland, EFFECTS OF CHRONIC TREATMENT WITH THE GABA-TRANSAMINASE INHIBITOR VIGABATRIN ON EXPLORATORY-BEHAVIOR IN RATS, Behavioural brain research, 63(1), 1994, pp. 11-15
Vigabatrin (gamma-vinyl GABA, GVG) is an irreversible inhibitor of the
enzyme GABA-transaminase (GABA-T). GABA-T is the enzyme responsible f
or the catabolism of the major inhibitory neurotransmitter gamma-amino
butyric acid (GABA) in the mammalian brain. Previously, a single admin
istration of vigabatrin at a dose of 50 mg/kg was found to produce an
anxiolytic-like effect on exploratory behaviour in rats and a decrease
in the locomotor activity, 2 and 4 h after the injection and: present
ly, 24 h after the injection. Using an elevated plus-maze and open fie
ld tests, we investigated whether or not chronic administration of vig
abatrin at the same dose (50 mg/kg/day, i.p.) for 14 and 28 days induc
es tolerance with regard to these effects. The anxiolytic-like effect
of vigabatrin was found to persist in the elevated plus-maze test, as
was the case with diazepam (5 mg/kg/day, i.p.), 24 h after the last in
jection. However, in the plus-maze and open field tests, the effects o
f vigabatrin and diazepam on the general locomotor activity were not f
ound to be decreased.